Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study

F Azizi1, F Raiszadeh, P Salehi

  • 1Endocrine Research Center, Shaheed Beheshti University of Medical Sciences, Tehran, Iran. Azizi@erc-iran.com

Insights

Low high-density lipoprotein cholesterol (HDL-C) is linked to coronary artery disease (CAD). This study identified hypertriglyceridemia, male sex, smoking, obesity, and passive smoking as key determinants of low HDL-C in a Tehran population.

Area of Science:

  • Cardiovascular Medicine
  • Lipidology
  • Public Health

Background:

  • Decreased serum high-density lipoprotein cholesterol (HDL-C) is a common lipid disorder in patients with coronary artery disease (CAD).
  • Low HDL-C levels significantly increase the risk of CAD.
  • Understanding HDL-C determinants is crucial for CAD prevention strategies.

Purpose of the Study:

  • To investigate the determinants of serum HDL-C levels in a Tehran population.
  • To identify modifiable risk factors associated with low HDL-C.
  • To inform community-based CAD prevention programs.

Main Methods:

  • A cross-sectional study of 9514 subjects (aged 20-69) from the Tehran Lipid and Glucose Study (TLGS).
  • Data collection included personal history (smoking, physical activity), clinical examination, and biochemical measurements (serum lipids, OGTT).
  • Multiple stepwise regression analysis was used to identify determinants of serum HDL-C.

Main Results:

  • Women had significantly higher mean HDL-C than men (45 vs. 38 mg/dL).
  • Low HDL-C (<35 mg/dL) was more prevalent in men (31%) than women (13%).
  • Key determinants of low HDL-C included hypertriglyceridemia, male sex, cigarette smoking, obesity, age, high waist-to-hip ratio (WHR), and passive smoking.

Conclusions:

  • Hypertriglyceridemia, male sex, smoking (active and passive), and obesity are significant modifiable determinants of HDL-C levels.
  • Age and sex are unmodifiable factors influencing HDL-C.
  • These findings can guide community CAD prevention programs by targeting identified risk factors.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...